(Q33389749)

26 July 2017

title

Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

1 reference

1 reference

Vural Taner Yılmaz

1

1 reference

26 July 2017

Hüseyin Koçak

2

1 reference

26 July 2017

Ali B Avcı

3

1 reference

26 July 2017

Ozan Salim

4

1 reference

26 July 2017

Fevzi F Ersoy

5

1 reference

26 July 2017

Gültekin Süleymanlar

6

1 reference

26 July 2017

publication date

22 May 2010

1 reference

International Urology and Nephrology

26 July 2017

published in

1 reference

26 July 2017

volume

43

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

581-584

1 reference

Thrombotic microangiopathy after kidney transplantation

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

Thrombotic microangiopathy in marginal kidneys after sirolimus use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

Retinal injury as an early manifestation of posttransplant thrombotic microangiopathy: recovery with plasma exchanges and conversion to sirolimus--case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

The thrombotic microangiopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

Severe everolimus-associated pneumonitis in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9755-2

Thrombotic microangiopathy in renal transplantation.

21 January 2018

1 reference

12 December 2020

Cyclosporine withdrawal in post-renal transplant thrombotic microangiopathy

1 reference

12 December 2020

Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA.

1 reference

12 December 2020

Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange

1 reference

12 December 2020

10.1007/S11255-010-9755-2

Identifiers

DOI

1 reference

26 July 2017

1 reference